Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial

NCT05996783 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT05996783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05996783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial
Lead sponsor
Universiteit Antwerpen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 25, 2023
Completion date
September 30, 2026
Enrollment
48,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia, cervix cancer, hpv-related cervical carcinoma, human papilloma virus